phoxillum bk4/2.5- calcium chloride, magnesium chloride, sodium chloride, potassium chloride, sodium phosphate, dibasic, and so
gambro renal products - calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838, chloride ion - unii:q32zn48698), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), sodium phosphate, dibasic (unii: gr686lba74) (sodium cation - unii:lyr4m0nh37, phosphate i - calcium chloride 0.139 g in 1 l - prismasol and phoxillum solutions are indicated in pediatric and adult patients for use as a replacement solution in continuous renal replacement therapy (crrt) to replace plasma volume removed by ultrafiltration and to correct electrolyte and acid-base imbalances.they may also be used in case of drug poisoning when crrt is used to remove dialyzable substances. none pregnancy category c animal reproduction studies have not been conducted with prismasol and phoxillum solutions. while there are no adequate and well controlled studies in pregnant women, appropriate administration of prismasol and phoxillum solutions with monitoring of fluid, electrolyte, acid-base and glucose balance, is not expected to cause fetal harm, or affect reproductive capacity. maintenance of normal acid-base balance is important for fetal well-being. the components of prismasol and phoxillum solutions are excreted in human milk. appropriate administration of prismasol and phoxillum solutions with monitoring of fluid, electrolyte, acid-
prismasol bgk0/2.5- calcium chloride, magnesium chloride, dextrose monohydrate, lactic acid, sodium chloride, and sodium bicarb
gambro renal products - calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838, chloride ion - unii:q32zn48698), dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), lactic acid (unii: 33x04xa5at) (lactic acid - unii:33x04xa5at), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), sodium bicarbonate (unii: 8mdf5v39qo) (sodium cation - - calcium chloride 0.139 g in 1 l - there is no known contraindication to the use of prismasol solution. pregnancy category c. prismasol solution is a replacement solution of electrolytes, bicarbonate and dextrose and is pharmacologically inactive. animal reproduction studies have not been conducted with prismasol solution. while there are no adequate and well controlled studies in pregnant women, appropriate administration of prismasol solution with monitoring of fluid, electrolyte, acid-base and glucose balance, is not expected to cause fetal harm, or affect reproductive capacity. maintenance of normal acid-base balance is important for fetal well being. prismasol solution is a replacement solution of electrolytes, bicarbonate and dextrose and is pharmacologically inactive. the components of prismasol solution are excreted in human milk. appropriate administration of prismasol solution with monitoring of fluid, electrolyte, acid-base and glucose balance, is not expected to harm a nursing infant. safety and effectiveness have been established
balance 1,5% glucose 1,75 mmol/l calcium solution pour dialyse péritonéale
fresenius medical care deutschland - glucose monohydraté; chlorure de magnésium hexahydraté; lactate de sodium; chlorure de sodium; chlorure de calcium dihydraté - solution pour dialyse péritonéale - glucose monohydraté; chlorure de magnésium hexahydraté 0.1017 mg/ml; lactate de sodium 3.93 mg/ml; chlorure de sodium 5.64 mg/ml; chlorure de calcium dihydraté - hypertonic solutions
balance 2,3 % glucose 1,75 mmol/l calcium solution pour dialyse péritonéale
fresenius medical care deutschland - glucose monohydraté; chlorure de magnésium hexahydraté; chlorure de sodium; lactate de sodium; chlorure de calcium dihydraté - solution pour dialyse péritonéale - glucose monohydraté; chlorure de magnésium hexahydraté 0.1017 mg/ml; chlorure de sodium 5.64 mg/ml; lactate de sodium 3.93 mg/ml; chlorure de calcium dihydraté - hypertonic solutions
balance 4,25 % glucose 1,75 mmol/l calcium solution pour dialyse péritonéale
fresenius medical care deutschland - glucose monohydraté; chlorure de magnésium hexahydraté; chlorure de sodium; lactate de sodium; chlorure de calcium dihydraté - solution pour dialyse péritonéale - glucose monohydraté; chlorure de magnésium hexahydraté 0.1017 mg/ml; chlorure de sodium 5.64 mg/ml; lactate de sodium 3.93 mg/ml; chlorure de calcium dihydraté - hypertonic solutions
balance 1,5% glucose 1,75 mmol/l calcium oplossing voor peritoneale dialyse
fresenius medical care deutschland - glucosemonohydraat; magnesiumchloridehexahydraat; natriumlactaat; natriumchloride; calciumchloridedihydraat - oplossing voor peritoneale dialyse - glucosemonohydraat; magnesiumchloridehexahydraat 0.1017 mg/ml; natriumlactaat 3.93 mg/ml; natriumchloride 5.64 mg/ml; calciumchloridedihydraat - hypertonic solutions
balance 2,3 % glucose 1,75 mmol/l calcium oplossing voor peritoneale dialyse
fresenius medical care deutschland - glucosemonohydraat; magnesiumchloridehexahydraat; natriumchloride; natriumlactaat; calciumchloridedihydraat - oplossing voor peritoneale dialyse - glucosemonohydraat; magnesiumchloridehexahydraat 0.1017 mg/ml; natriumchloride 5.64 mg/ml; natriumlactaat 3.93 mg/ml; calciumchloridedihydraat - hypertonic solutions
balance 4,25 % glucose 1,75 mmol/l calcium oplossing voor peritoneale dialyse
fresenius medical care deutschland - glucosemonohydraat; magnesiumchloridehexahydraat; natriumchloride; natriumlactaat; calciumchloridedihydraat - oplossing voor peritoneale dialyse - glucosemonohydraat; magnesiumchloridehexahydraat 0.1017 mg/ml; natriumchloride 5.64 mg/ml; natriumlactaat 3.93 mg/ml; calciumchloridedihydraat - hypertonic solutions
glucose sterop 500 mg/ml sol. perf. i.v. amp.
laboratoires sterop sa-nv - glucose monohydraté 550 mg/ml - eq. glucose anhydre 500 mg/ml - solution pour perfusion - 500 mg/ml - glucose monohydraté 550 mg/ml - carbohydrates
glucose sterop 500 mg/ml sol. perf. i.v. amp.
laboratoires sterop sa-nv - glucose monohydraté 550 mg/ml - eq. glucose anhydre 500 mg/ml - solution pour perfusion - 500 mg/ml - glucose monohydraté 550 mg/ml - carbohydrates